For: | Cuadrado E, Alonso M, Juan MD, Echaniz P, Arenas JI. Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis. World J Gastroenterol 2008; 14(10): 1521-1527 [PMID: 18330941 DOI: 10.3748/wjg.14.1521] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i10/1521.htm |
Number | Citing Articles |
1 |
Fumie Jimma, Yuji Takeda, Kenta Kaneda, Ichiro Wakabayashi. Induction of Foxp3 expression in T cells by cellulose acetate beads in vitro. Journal of Clinical Apheresis 2010; 25(4): 216 doi: 10.1002/jca.20243
|
2 |
H Hanai, Y Takeda, M Eberhardson, R Gruber, A R Saniabadi, O Winqvist, R Lofberg. The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review. Clinical and Experimental Immunology 2010; 163(1): 50 doi: 10.1111/j.1365-2249.2010.04279.x
|
3 |
Emilio Cuadrado. Granulocyte/monocyte apheresis as immunotherapic tool: Cellular adsorption and immune modulation. Autoimmunity Reviews 2009; 8(4): 292 doi: 10.1016/j.autrev.2008.09.001
|
4 |
J.L. Cabriada, I. Rodríguez-Lago. Granulocitoaféresis en 2017. Puesta al día. Enfermedad Inflamatoria Intestinal al Día 2017; 16(2): 62 doi: 10.1016/j.eii.2016.12.001
|
5 |
Paola Contini, Simone Negrini, Giorgia Bodini, Cecilia Trucchi, Gianluca Ubezio, Paolo Strada, Vincenzo Savarino, Massimo Ghio. Granulocytes and monocytes apheresis induces upregulation of TGFβ1 in patients with active ulcerative colitis: A possible involvement of soluble HLA‐I. Journal of Clinical Apheresis 2017; 32(1): 49 doi: 10.1002/jca.21466
|
6 |
Naoki Yoshimura, Yoko Yokoyama, Katsuyoshi Matsuoka, Hiroki Takahashi, Ryuichi Iwakiri, Takayuki Yamamoto, Tomoo Nakagawa, Takumi Fukuchi, Satoshi Motoya, Reiko Kunisaki, Shingo Kato, Fumihito Hirai, Yoh Ishiguro, Satoshi Tanida, Sakiko Hiraoka, Keiichi Mitsuyama, Shunji Ishihara, Shinji Tanaka, Michiro Otaka, Taro Osada, Takashi Kagaya, Yasuo Suzuki, Hiroshi Nakase, Hiroyuki Hanai, Kenji Watanabe, Nobuhito Kashiwagi, Toshifumi Hibi. An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn’s disease. BMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0390-3
|
7 |
Megan Garrity-Park, Edward V. Loftus, William J. Sandborn, Thomas C. Smyrk. Myeloperoxidase Immunohistochemistry as a Measure of Disease Activity in Ulcerative Colitis: Association With Ulcerative Colitis-Colorectal Cancer, Tumor Necrosis Factor Polymorphism and RUNX3 Methylation. Inflammatory Bowel Diseases 2012; 18(2): 275 doi: 10.1002/ibd.21681
|
8 |
Cristina Suárez Ferrer, Eduardo Martin-Arranz, María Dolores Martín-Arranz. Selective granulocyte–monocyte apheresis during induction with vedolizumab in moderate–severe ulcerative colitis: Experience in a tertiary hospital. Gastroenterología y Hepatología (English Edition) 2024; 47(7): 721 doi: 10.1016/j.gastre.2024.04.037
|
9 |
Shigaku Ikeda, Hidetoshi Takahashi, Yasushi Suga, Hikaru Eto, Takafumi Etoh, Keiko Okuma, Kazuo Takahashi, Takeshi Kanbara, Mariko Seishima, Akimichi Morita, Yasutomo Imai, Takuro Kanekura. Therapeutic depletion of myeloid lineage leukocytes in patients with generalized pustular psoriasis indicates a major role for neutrophils in the immunopathogenesis of psoriasis. Journal of the American Academy of Dermatology 2013; 68(4): 609 doi: 10.1016/j.jaad.2012.09.037
|
10 |
Yoko Yokoyama, Koji Sawada, Nobuo Aoyama, Naoki Yoshimura, Minako Sako, Fumihito Hirai, Nobuhito Kashiwagi, Yasuo Suzuki. Efficacy of Granulocyte and Monocyte Adsorptive Apheresis in Patients With Inflammatory Bowel Disease Showing Lost Response to Infliximab. Journal of Crohn's and Colitis 2020; 14(9): 1264 doi: 10.1093/ecco-jcc/jjaa051
|
11 |
Eugeni Domènech, Joan-Ramon Grífols, Ayesha Akbar, Axel U Dignass. Use of granulocyte/monocytapheresis in ulcerative colitis: A practical review from a European perspective. World Journal of Gastroenterology 2021; 27(10): 908-918 doi: 10.3748/wjg.v27.i10.908
|
12 |
Iago Rodríguez-Lago, Fiorella Cañete, Elena Guerra-del-Río, Claudia Herrera-deGuise, Eva Iglesias, Eduardo Leo, Yamile Zabana, Manuel Barreiro-de Acosta, Daniel Ginard, José Luis Cabriada. Combination of granulocyte–monocyte apheresis and tofacitinib: Multicentre and retrospective study. Gastroenterología y Hepatología (English Edition) 2024; 47(7): 727 doi: 10.1016/j.gastre.2024.04.052
|
13 |
Yosuke Toya, Toshimi Chiba, Tomomi Mizutani, Kunihiko Sato, Satoshi Kasugai, Nozomi Matsuda, Shunsuke Orikasa, Sho Shibata, Yukito Abiko, Risaburo Akasaka, Naoki Yokoyama, Shuhei Oana, Shigeru Hirota, Masaki Endo, Kazuyuki Suzuki. The effect of granulocyte and monocyte adsorptive apheresis on serum cytokine levels in patients with ulcerative colitis. Cytokine 2013; 62(1): 146 doi: 10.1016/j.cyto.2013.01.019
|
14 |
Yuko Higashi, Atsuko Ibusuki, Naoko Baba, Miho Hatanaka, Ko‐Ichi Tada, Takuro Kanekura. Granulocyte and monocyte adsorptive apheresis for pyoderma gangrenosum. Therapeutic Apheresis and Dialysis 2022; 26(2): 450 doi: 10.1111/1744-9987.13720
|
15 |
Jose L. Cabriada, Nora Ibargoyen, Anaiansi Hernández, Antonio Bernal, Agustín Castiella. Sustained remission after steroids and leukocytapheresis induced response in steroid-dependent ulcerative colitis: Results at 1 year. Digestive and Liver Disease 2010; 42(6): 432 doi: 10.1016/j.dld.2009.09.001
|
16 |
Chiara De Cassan, Edoardo Savarino, Piero Marson, Tiziana Tison, Giorgia Hatem, Giacomo Carlo Sturniolo, Renata D’Incà. Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease. World Journal of Gastroenterology 2014; 20(45): 17155-17162 doi: 10.3748/wjg.v20.i45.17155
|
17 |
Cristina Suárez Ferrer, Eduardo Martin-Arranz, María Dolores Martín-Arranz. Selective granulocyte–monocyte apheresis during induction with vedolizumab in moderate–severe ulcerative colitis: Experience in a tertiary hospital. Gastroenterología y Hepatología 2024; 47(7): 721 doi: 10.1016/j.gastrohep.2024.01.002
|
18 |
Iago Rodríguez-Lago, Fiorella Cañete, Elena Guerra-del-Río, Claudia Herrera-deGuise, Eva Iglesias, Eduardo Leo, Yamile Zabana, Manuel Barreiro-de Acosta, Daniel Ginard, José Luis Cabriada. Combination of granulocyte–monocyte apheresis and tofacitinib: Multicentre and retrospective study. Gastroenterología y Hepatología 2024; 47(7): 727 doi: 10.1016/j.gastrohep.2024.01.004
|
19 |
Iago Rodríguez-Lago, Leticia Abecia, Iratxe Seoane, Juan Anguita, José Luis Cabriada. An in vitro analysis of the interaction between infliximab and granulocyte–monocyte apheresis. Gastroenterología y Hepatología 2024; 47(4): 347 doi: 10.1016/j.gastrohep.2023.07.001
|
20 |
Gerda C Leitner, Harald Vogelsang. Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults. World Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(1): 5-20 doi: 10.4292/wjgpt.v7.i1.5
|
21 |
Takanori Kanai. Crohn's Disease and Ulcerative Colitis. 2017; : 491 doi: 10.1007/978-3-319-33703-6_49
|
22 |
Takuro Kanekura, Mariko Seishima, Masaru Honma, Takafumi Etou, Hikaru Eto, Keiko Okuma, Yukari Okubo, Yukie Yamaguchi, Takeshi Kambara, Tomotaka Mabuchi, Yasushi Suga, Akimichi Morita, Kiyofumi Yamanishi, Daisuke Tsuruta, Kei Itoh, Ken Yamaji, Shigaku Ikeda. Therapeutic depletion of myeloid lineage leukocytes by adsorptive apheresis for psoriatic arthritis: Efficacy of a non‐drug intervention for patients refractory to pharmacologics. The Journal of Dermatology 2017; 44(12): 1353 doi: 10.1111/1346-8138.13975
|
23 |
Shuzo Kaneko, Tsuyoshi Zen, Susumu Banjoya, Toshiaki Nuki, Ainori Hoshimoto, Makiko Harano, Sou Hagiwara, Eri Imai, Yusuke Tsukamoto. Successful Use of Granulocyte and Monocyte Adsorptive Apheresis in a Patient with Post-COVID-19 Multisystem Inflammatory Syndrome in Adults. Internal Medicine 2023; 62(17): 2565 doi: 10.2169/internalmedicine.1728-23
|
24 |
Toshimi Chiba, Mikiya Endo, Shoko Matsushita, Mika Sasaki, Shoichi Chida, Yosuke Toya, Satoshi Kasugai, Nozomi Matsuda, Shunsuke Orikasa, Yukito Abiko, Norihiko Kudara, Shuhei Oana, Masaki Endo, Kazuyuki Suzuki. Peripheral Blood CD64 Levels Decrease in Crohn’s Disease following Granulocyte and Monocyte Adsorptive Apheresis. Case Reports in Gastroenterology 2011; 5(3): 667 doi: 10.1159/000335316
|
25 |
Koji Sono, Akihiro Yamada, Yasushi Yoshimatsu, Nobuo Takada, Yasuo Suzuki. Factors associated with the loss of response to infliximab in patients with Crohn’s disease. Cytokine 2012; 59(2): 410 doi: 10.1016/j.cyto.2012.04.026
|
26 |
Wolfgang Ramlow, Grit Waitz, Gisela Sparmann, Heinrich Prophet, Peggy Bodammer, Jörg Emmrich. First Human Application of a Novel Adsorptive‐Type Cytapheresis Module in Patients With Active Ulcerative Colitis: A Pilot Study. Therapeutic Apheresis and Dialysis 2013; 17(3): 339 doi: 10.1111/1744-9987.12007
|
27 |
Takuro Kanekura. Clinical and immunological effects of adsorptive myeloid lineage leukocyte apheresis in patients with immune disorders. The Journal of Dermatology 2018; 45(8): 943 doi: 10.1111/1346-8138.14471
|
28 |
Masanao Sakanoue, Yuko Higashi, Takuro Kanekura. Inhibition of Inflammatory Cytokines and Induction of Myeloid‐Derived Suppressor Cells by the Effects of Granulocyte and Monocyte Adsorption Apheresis. Therapeutic Apheresis and Dialysis 2017; 21(6): 628 doi: 10.1111/1744-9987.12580
|
29 |
H H Olsen, V Muratov, K Cederlund, J Lundahl, A Eklund, J Grunewald. Therapeutic granulocyte and monocyte apheresis (GMA) for treatment refractory sarcoidosis: a pilot study of clinical effects and possible mechanisms of action. Clinical and Experimental Immunology 2014; 177(3): 712 doi: 10.1111/cei.12360
|
30 |
Takayuki Iida, Kentaro Ikeya, Masaichi Kato, Jinro Abe, Masayoshi Yamamoto, Fumitoshi Watanabe, Ken Sugimoto, Hiroyuki Hanai. Adsorptive Depletion of Myeloid Lineage Leucocytes as Remission Induction Therapy in Patients with Ulcerative Colitis after Failure of First-Line Medications: Results from a Three-Year Real World, Clinical Practice. Digestion 2017; 96(2): 119 doi: 10.1159/000479502
|
31 |
Shin-ichiro Takeda, Toru Sato, Tatsuro Katsuno, Tomoo Nakagawa, Yoshiko Noguchi, Osamu Yokosuka, Yasushi Saito. Adsorptive Depletion of α4 Integrinhi- and CX3CR1hi-Expressing Proinflammatory Monocytes in Patients with Ulcerative Colitis. Digestive Diseases and Sciences 2010; 55(7): 1886 doi: 10.1007/s10620-009-0974-2
|
32 |
Esteban Sáez-González, Inés Moret, Diego Alvarez-Sotomayor, Francia Carolina Díaz-Jaime, Elena Cerrillo, Marisa Iborra, Pilar Nos, Belén Beltrán. Immunological Mechanisms of Adsorptive Cytapheresis in Inflammatory Bowel Disease. Digestive Diseases and Sciences 2017; 62(6): 1417 doi: 10.1007/s10620-017-4577-z
|
33 |
Iago Rodríguez-Lago, Leticia Abecia, Iratxe Seoane, Juan Anguita, José Luis Cabriada. An in vitro analysis of the interaction between infliximab and granulocyte–monocyte apheresis. Gastroenterología y Hepatología (English Edition) 2024; 47(4): 347 doi: 10.1016/j.gastre.2023.07.005
|
34 |
Ryoko SHUKUYA, Toshio HASEGAWA, Yusuke NIWA, Keiko OKUMA, Shigaku IKEDA. Granulocyte and monocyte adsorption apheresis for generalized pustular psoriasis. The Journal of Dermatology 2011; 38(12): 1130 doi: 10.1111/j.1346-8138.2011.01279.x
|
35 |
Ali Khalili, Soheil Ebrahimpour, Iradj Maleki, Saeid Abediankenari, Mousa Mohammadnia Afrouzi. CD4+CD25+CD127low FoxP3+ regulatory T cells in Crohn’s disease. Romanian Journal of Internal Medicine 2018; 56(3): 158 doi: 10.2478/rjim-2018-0006
|
36 |
Tomoyoshi Shibuya, Osamu Nomura, Kei Nomura, Mayuko Haraikawa, Keiichi Haga, Dai Ishikawa, Taro Osada, Ken Yamaji, Shigaku Ikeda, Akihito Nagahara. Efficacy of cytapheresis for induction therapy and extra‐intestinal skin manifestations of ulcerative colitis. Therapeutic Apheresis and Dialysis 2022; 26(3): 522 doi: 10.1111/1744-9987.13823
|
37 |
Ayako Yoshida, Kiyoshi Yamada, Yasumasa Yamazaki, Toshihiro Sashihara, Shuuji Ikegami, Makoto Shimizu, Mamoru Totsuka. Lactobacillus gasseri OLL2809 and its RNA suppress proliferation of CD4+ T cells through a MyD88-dependent signalling pathway. Immunology 2011; 133(4): 442 doi: 10.1111/j.1365-2567.2011.03455.x
|
38 |
Y Takeda, K Kaneda, F Jimma, N Shiobara, M Hidaka, A R Saniabadi, I Wakabayashi. Inhibition of CXCL10 release by monomeric C3bi and C4b. Clinical and Experimental Immunology 2011; 167(1): 149 doi: 10.1111/j.1365-2249.2011.04490.x
|